FDA Commissioner Marty Makary Resigns Amidst Leadership Turbulence

FDA Commissioner Marty Makary resigned following widespread criticism over his handling of key issues, including flavored vapes and vaccine reviews. His departure follows pressure from various political and industry groups. The White House is currently searching for a permanent replacement to lead the health agency.

Marty Makary has stepped down as the U.S. Food and Drug Administration Commissioner, a move announced by President Donald Trump amidst leadership changes in the federal health department. The decision comes amid heightened speculation and pressure on Makary to resign from influential political and industry figures.

FDA Deputy Commissioner for Food, Kyle Diamantas, will temporarily take the helm until a permanent replacement is found. Critics have scrutinized Makary for his approach to issues such as flavored vapes and his resistance to certain drug reviews, fueled further by tension with other top health officials.

The White House is actively pursuing more conventional candidates for the position amid challenges in securing someone willing to work under current conditions, including staffing challenges. Makary's resignation intensifies the ongoing dialogue regarding the future direction of the FDA.